These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 30062962)

  • 21. Enhancing using glucose encapsulation, the efficacy of CdO NPs against multi-drug resistant Escherichia coli.
    Zahera M; Khan SA; Khan IA; Elgorban AM; Bahkali AH; Alghamdi SM; Khan MS
    Microb Pathog; 2018 Jun; 119():42-48. PubMed ID: 29635050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria.
    Rai MK; Deshmukh SD; Ingle AP; Gade AK
    J Appl Microbiol; 2012 May; 112(5):841-52. PubMed ID: 22324439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-bacterial activity of graphene oxide as a new weapon nanomaterial to combat multidrug-resistance bacteria.
    Yousefi M; Dadashpour M; Hejazi M; Hasanzadeh M; Behnam B; de la Guardia M; Shadjou N; Mokhtarzadeh A
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():568-581. PubMed ID: 28254332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the potential of metal and metal oxide nanomaterials for sustainable water and wastewater treatment: A review of their antimicrobial properties.
    Kamyab H; Chelliapan S; Hayder G; Yusuf M; Taheri MM; Rezania S; Hasan M; Yadav KK; Khorami M; Farajnezhad M; Nouri J
    Chemosphere; 2023 Sep; 335():139103. PubMed ID: 37271472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interfacial Engineering of Bimetallic Ag/Pt Nanoparticles on Reduced Graphene Oxide Matrix for Enhanced Antimicrobial Activity.
    Zhang M; Zhao Y; Yan L; Peltier R; Hui W; Yao X; Cui Y; Chen X; Sun H; Wang Z
    ACS Appl Mater Interfaces; 2016 Apr; 8(13):8834-40. PubMed ID: 27007980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adsorption of Silver Nanoparticles onto Different Surface Structures of Chitin/Chitosan and Correlations with Antimicrobial Activities.
    Ishihara M; Nguyen VQ; Mori Y; Nakamura S; Hattori H
    Int J Mol Sci; 2015 Jun; 16(6):13973-88. PubMed ID: 26096004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticles and their antimicrobial properties against pathogens including bacteria, fungi, parasites and viruses.
    Khezerlou A; Alizadeh-Sani M; Azizi-Lalabadi M; Ehsani A
    Microb Pathog; 2018 Oct; 123():505-526. PubMed ID: 30092260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do physico-chemical properties of silver nanoparticles decide their interaction with biological media and bactericidal action? A review.
    Pareek V; Gupta R; Panwar J
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():739-749. PubMed ID: 29853145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silver nanoparticles as an alternative strategy against bacterial biofilms.
    Markowska K; Grudniak AM; Wolska KI
    Acta Biochim Pol; 2013; 60(4):523-30. PubMed ID: 24432308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silver nanoparticles functionalized with ampicillin.
    Rogowska A; Rafińska K; Pomastowski P; Walczak J; Railean-Plugaru V; Buszewska-Forajta M; Buszewski B
    Electrophoresis; 2017 Nov; 38(21):2757-2764. PubMed ID: 28704596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Review on Nano-Antimicrobials: Metal Nanoparticles, Methods and Mechanisms.
    Hoseinzadeh E; Makhdoumi P; Taha P; Hossini H; Stelling J; Kamal MA; Ashraf GM
    Curr Drug Metab; 2017; 18(2):120-128. PubMed ID: 27908256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inorganic Nanoparticles and Composite Films for Antimicrobial Therapies.
    Spirescu VA; Chircov C; Grumezescu AM; Vasile BȘ; Andronescu E
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial effects and protein corona evaluations: crucial ignored factors in the prediction of bio-efficacy of various forms of silver nanoparticles.
    Ashkarran AA; Ghavami M; Aghaverdi H; Stroeve P; Mahmoudi M
    Chem Res Toxicol; 2012 Jun; 25(6):1231-42. PubMed ID: 22551528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibacterial mechanisms of a novel type picosecond laser-generated silver-titanium nanoparticles and their toxicity to human cells.
    Korshed P; Li L; Liu Z; Mironov A; Wang T
    Int J Nanomedicine; 2018; 13():89-101. PubMed ID: 29317818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
    Natan M; Banin E
    FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered Nanoparticles with Antimicrobial Property.
    Reshma VG; Syama S; Sruthi S; Reshma SC; Remya NS; Mohanan PV
    Curr Drug Metab; 2017; 18(11):1040-1054. PubMed ID: 28952436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface modification minimizes the toxicity of silver nanoparticles: an in vitro and in vivo study.
    Das B; Tripathy S; Adhikary J; Chattopadhyay S; Mandal D; Dash SK; Das S; Dey A; Dey SK; Das D; Roy S
    J Biol Inorg Chem; 2017 Aug; 22(6):893-918. PubMed ID: 28643149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bactericidal impact of Ag, ZnO and mixed AgZnO colloidal nanoparticles on H
    Jafari A; Mosavari N; Movahedzadeh F; Nodooshan SJ; Safarkar R; Moro R; Kamalzadeh M; Majidpour A; Boustanshenas M; Mosavi T
    Microb Pathog; 2017 Sep; 110():335-344. PubMed ID: 28710015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.
    Jain J; Arora S; Rajwade JM; Omray P; Khandelwal S; Paknikar KM
    Mol Pharm; 2009; 6(5):1388-401. PubMed ID: 19473014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.